Free Trial

AdvanSix (ASIX) to Release Quarterly Earnings on Friday

AdvanSix logo with Basic Materials background

AdvanSix (NYSE:ASIX - Get Free Report) will likely be releasing its Q1 2025 earnings data before the market opens on Friday, May 2nd. Analysts expect AdvanSix to announce earnings of $0.83 per share and revenue of $347.25 million for the quarter.

AdvanSix (NYSE:ASIX - Get Free Report) last released its quarterly earnings results on Friday, February 21st. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.37) by $0.40. The company had revenue of $329.06 million during the quarter, compared to the consensus estimate of $377.15 million. AdvanSix had a net margin of 2.91% and a return on equity of 6.26%.

AdvanSix Stock Down 0.6 %

AdvanSix stock traded down $0.12 during trading hours on Monday, hitting $20.98. 319,228 shares of the stock traded hands, compared to its average volume of 144,984. AdvanSix has a one year low of $18.44 and a one year high of $33.00. The firm's 50-day moving average price is $23.37 and its two-hundred day moving average price is $27.73. The company has a current ratio of 1.08, a quick ratio of 0.49 and a debt-to-equity ratio of 0.25. The company has a market cap of $562.43 million, a PE ratio of 13.03 and a beta of 1.64.

AdvanSix Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 24th. Stockholders of record on Monday, March 10th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.05%. The ex-dividend date was Monday, March 10th. AdvanSix's payout ratio is presently 39.75%.

Analysts Set New Price Targets

Several brokerages have commented on ASIX. StockNews.com lowered AdvanSix from a "buy" rating to a "hold" rating in a research report on Monday, March 24th. Piper Sandler cut shares of AdvanSix from an "overweight" rating to a "neutral" rating and lowered their price target for the company from $35.00 to $26.00 in a research report on Monday, April 7th. Finally, UBS Group set a $35.00 price objective on shares of AdvanSix in a research note on Tuesday, March 18th.

Get Our Latest Analysis on AdvanSix

Insider Buying and Selling at AdvanSix

In other AdvanSix news, CEO Erin N. Kane sold 5,000 shares of AdvanSix stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $30.19, for a total value of $150,950.00. Following the completion of the transaction, the chief executive officer now directly owns 502,795 shares of the company's stock, valued at approximately $15,179,381.05. The trade was a 0.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Achilles B. Kintiroglou sold 4,000 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $22.24, for a total transaction of $88,960.00. Following the sale, the senior vice president now owns 36,363 shares in the company, valued at approximately $808,713.12. The trade was a 9.91 % decrease in their position. The disclosure for this sale can be found here. 5.60% of the stock is owned by company insiders.

AdvanSix Company Profile

(Get Free Report)

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.

Featured Articles

Earnings History for AdvanSix (NYSE:ASIX)

Should You Invest $1,000 in AdvanSix Right Now?

Before you consider AdvanSix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.

While AdvanSix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines